Beta Bionics, Inc. - Common Stock (BBNX)
Beta Bionics, Inc. - Common Stock (BBNX) last closed at $19.34 (as of 2026-10-22). On Shishin's four-engine momentum model it scored 27/100, flagged by the Byakko engine on its most recent scan appearance (2026-10-23). It has surfaced in 7 daily scans since 2026-08-14. The figures below are research data, the Shishin Score and the momentum, trend, and volatility indicators the engines observe, not investment advice.
Price updates daily; the engine read reflects BBNX's most recent scan appearance. Shishin's live daily signals are published each morning on the rankings board.
BBNX is in Shishin's signals for 2026-10-23, flagged by the Byakko engine, with a composite momentum score of 27/100.
BBNX's Shishin Score has faded 34 points (from 61 to 27/100) across its recent scans, momentum-of-score is cooling.
What is BBNX's Shishin momentum score?
As of 2026-10-23, BBNX scores 27/100 on Shishin's four-engine composite, flagged by the Byakko engine. The score blends momentum, trend, and volatility indicators on a 0 to 100 scale.
Is BBNX showing a momentum setup?
BBNX's current setup state is "OTHER." This describes what the engines observe in the chart structure, it is a data classification, not a recommendation to buy or sell.
Which Shishin engine flags BBNX?
Most recently the Byakko engine; across its history BBNX has been flagged by: Byakko, Suzaku. Each of the four guardians is tuned for a different market regime.
How often has BBNX appeared in Shishin scans?
BBNX has appeared in 7 daily scans since 2026-08-14. Recurring appearances indicate a persistent setup; one-off appearances are more transient.
How is the Shishin Score calculated?
The Shishin Score (0 to 100) is a weighted blend of momentum (multi-horizon returns), trend (moving-average stack, distance from MAs), and volatility/liquidity (ADR, ATR, dollar volume) indicators, scored per the engine active for the current market regime.
Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.